About Brainomix
Brainomix is a company based in Oxford (United Kingdom) founded in 2010 by Andrew Charles Barker. Brainomix has raised $62.42 million across 10 funding rounds from investors including Tencent, Boehringer Ingelheim and IP Group. The company has 29 employees as of December 31, 2019. Brainomix offers products and services including Brainomix 360 Stroke, e-Lung, and Cancer AI Solution. Brainomix operates in a competitive market with competitors including AIdoc, HeartFlow, IXICO, Median and AI Medical Service, among others.
- Headquarter Oxford, United Kingdom
- Employees 29 as on 31 Dec, 2019
- Founders Andrew Charles Barker
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Brainomix Limited
- Date of Incorporation 02 Nov, 2010
- Jurisdiction OXFORD, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$62.42 M (USD)
in 10 rounds
-
Latest Funding Round
$6.5 M (USD), Series C
Feb 24, 2026
-
Investors
Tencent
& 9 more
-
Employee Count
29
as on Dec 31, 2019
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Brainomix
Brainomix offers a comprehensive portfolio of products and services, including Brainomix 360 Stroke, e-Lung, and Cancer AI Solution.
Automated AI solution for stroke assessment and decision support
AI-powered tool for evaluating interstitial lung diseases
Automated system for assessing solid tumors in clinical trials
People of Brainomix
Unlock access to complete
Unlock access to complete
Funding Insights of Brainomix
Brainomix has successfully raised a total of $62.42M across 10 strategic funding rounds. The most recent funding activity was a Series C round of $6.5 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Brainomix
Brainomix has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Tencent, Boehringer Ingelheim and IP Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech companies are invested in by Parkwalk venture capital firm.
|
Locked | Locked | Locked | |
|
Venture capital and advisory services are offered across multiple sectors.
|
Locked | Locked | Locked | |
|
Healthcare investments are targeted by Boehringer Ingelheim Venture Fund.
|
Locked | Locked | Locked |
Investor details for Brainomix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Brainomix
Investment portfolio details for Brainomix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Brainomix
Detailed financials for Brainomix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Brainomix Comparisons
Peer comparison for Brainomix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Brainomix
Brainomix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AIdoc, HeartFlow, IXICO, Median and AI Medical Service, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based single-screen system is provided to streamline medical imaging.
|
|
| Locked | Locked | Locked |
Cardiovascular diagnostics are provided using CT scans and analytics.
|
|
| Locked | Locked | Locked |
AI-based medical image management and analysis solutions for healthcare organizations
|
|
| Locked | Locked | Locked |
Medical imaging software and services are provided for clinical trials.
|
|
| Locked | Locked | Locked |
Provider of AI-based solution for diagnosis of cancer related lesions
|
|
| Locked | Locked | Locked |
Robotic surgery platform for bone procedures is developed.
|
Detailed competitors of Brainomix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Brainomix
Complete news archive for Brainomix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brainomix
Brainomix was founded in 2010 and raised its 1st funding round 4 years after it was founded.
Brainomix is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Brainomix is a funded company, having raised a total of $62.42M across 10 funding rounds to date.
As of Dec 31, 2019, the latest employee count at Brainomix is 29.
Brainomix was founded in 2010 and is based in Oxford, United Kingdom. AI-powered imaging biomarkers are developed for precision medicine in the medical imaging sector. Stroke imaging solutions, including e-ASPECTS, e-CTA, and e-CTP, are offered alongside e-ILD for Interstitial Lung Disease assessment. Medical imaging software is being created to interpret brain CT scans automatically, utilizing biomarkers for stroke diagnosis. Operations focus on automated analysis for clinical use.
Brainomix's top competitors include AIdoc, eCential Robotics and IXICO.
Brainomix offers Brainomix 360 Stroke, e-Lung, and Cancer AI Solution.
Brainomix has 10 investors. Key investors include Tencent, Boehringer Ingelheim, IP Group, European Union, and Oxford University Innovation.